ARGX.BR Current Ratio

The Current Ratio of argenx SE (ARGX.BR) is 7.29.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

ARGX.BR Current Ratio - Historical Value

Date	Value
2024-12-31	7.29
2023-12-31	9.75

ARGX.BR Current Ratio - Peers Comparison

Ticker	Name	Value
AVCT.L	Avacta Group PLC	7.95
CANTA.ST	Cantargia AB	3.04
PHM.MC	Pharma Mar SA	3.03
QURE	Uniqure NV	9.74
IDIA.SW	Idorsia Ltd	0.58
MRUS	Merus NV	6.54
NANO.PA	Nanobiotix SA	1.04
ORPHA.CO	Orphazyme A/S	3.81
OXB.L	Oxford Biomedica PLC	2.28
ABVX.PA	Abivax SA	1.82
ALCLS.PA	Cellectis SA	1.73
BSLN.SW	Basilea Pharmaceutica AG Allschwil	4.85
IPH.PA	Innate Pharma SA	2.60
IVA.PA	Inventiva SA	0.92
IVACC.ST	Intervacc AB	2.03
SNG.L	Synairgen PLC	9.01
VACC.OL	Vaccibody AS	17.38
ZEAL.CO	Zealand Pharma A/S	21.14
SLN.L	Silence Therapeutics PLC	2.99
VVY.AS	Vivoryon Therapeutics NV	7.20
FYB.DE	Formycon AG	2.80
GNS.L	Genus PLC	1.80
KDS.AS	Kiadis Pharma NV	0.22
MOLN.SW	Molecular Partners AG	14.31
SIGHT.PA	Gensight Biologics SA	0.24
HNSA.ST	Hansa Biopharma AB	2.29
PRQR	ProQR Therapeutics NV	3.95
MOR.DE	MorphoSys AG	3.08
MXCT.L	MaxCyte Inc	3.90
PHARM.AS	Pharming Group NV	3.77
RLF.SW	Relief Therapeutics Holding SA	3.95
ESP.AS	Esperite NV	0.56
GLPG.AS	Galapagos NV	9.97
GMAB.CO	Genmab A/S	5.25